Skip to main content

Table 6 Correlation between age group and antibiotic resistance profile among Gram-negative samples

From: Prevalence and resistance profile of bacteria isolated from wound infections among a group of patients in upper Egypt: a descriptive cross-sectional study

Antibiotic

Resistance profile

P-value*

Sensitive

Intermediate

Resistant

Ticracillin / Tazobactam

    

1–20

20–40

41–60

2

0

3

13

4

3

8

11

9

0.065

Tigycyclin

    

1–20

20–40

41–60

3

2

6

11

10

5

9

3

4

0.157

Chloramphenicol

    

1–20

20–40

41–60

7

7

7

4

2

2

12

6

6

0.838

Cefuroxime

    

1–20

20–40

41–60

4

0

2

3

3

1

16

12

12

0.448

Cefazolin

    

1–20

20–40

41–60

0

0

0

0

0

0

23

15

15

 N/A

Imipineme

    

1–20

20–40

41–60

10

4

5

3

2

5

10

9

5

0.369

Gentamycin

    

1–20

20–40

41–60

12

5

9

2

2

1

9

8

5

0.677

Ampicillin / Sulbactam

    

1–20

20–40

41–60

3

0

1

4

0

1

16

15

13

0.185

Amoxicillin/ Clavulanic

    

1–20

20–40

41–60

3

1

2

2

2

5

18

12

8

0.309

Ceftazidime

    

1–20

20–40

41–60

0

0

1

5

1

1

18

14

13

0.285

Levofloxacin

    

1–20

20–40

41–60

19

8

8

0

2

1

4

5

6

0.171

Ciprofloxacin

    

1–20

20–40

41–60

17

5

8

1

4

1

5

6

6

0.077

Trimethoprim / Sulfamethoxazole

    

1–20

20–40

41–60

6

5

3

5

3

3

12

8

8

0.942

  1. *Chi square test; P-value was set to 0.05; N/A: not applicaple